These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1128 related articles for article (PubMed ID: 7328599)

  • 21. New 2-substituted indoloquinone mitomycin analogues.
    Iyengar BS; Remers WA; Catino JJ
    J Med Chem; 1989 Aug; 32(8):1866-72. PubMed ID: 2754710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and antitumor activity of new mitomycin A analogues.
    Sami SM; Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1987 Jan; 30(1):168-73. PubMed ID: 3806593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumor activity of novel mitomycin derivatives containing functional groups at the C-6-methyl position.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Med Chem; 1994 Jun; 37(12):1794-804. PubMed ID: 8021918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships for mitomycin C and mitomycin A analogues.
    Kunz KR; Iyengar BS; Dorr RT; Alberts DS; Remers WA
    J Med Chem; 1991 Jul; 34(7):2281-6. PubMed ID: 1906109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic disulfide C8 iminoporfiromycin: nucleophilic activation of a porfiromycin.
    Lee SH; Kohn H
    J Am Chem Soc; 2004 Apr; 126(13):4281-92. PubMed ID: 15053618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
    Marshall RS; Paterson MC; Rauth AM
    Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity comparison of mitomycin C and mitomycin A analogues (review).
    Bradner WT; Remers WA; Vyas DM
    Anticancer Res; 1989; 9(4):1095-9. PubMed ID: 2510580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins.
    Kanda Y; Arai H; Ashizawa T; Morimoto M; Kasai M
    J Med Chem; 1992 Jul; 35(15):2781-6. PubMed ID: 1495011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551).
    Bradner WT; Catino JJ; Long BH; Rose WC; Schurig JE
    Anticancer Res; 1992; 12(3):959-64. PubMed ID: 1622154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
    Pan SS; Iracki T
    Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PORFIROMYCIN.
    DUVALL LR
    Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin C.
    Pattyn G; van Oosterom AT; de Bruijn EA; Tjaden UR
    J Chromatogr; 1991 Mar; 564(1):352-4. PubMed ID: 1860933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures.
    Rockwell S; Hughes CS
    Cell Prolif; 1994 Mar; 27(3):153-63. PubMed ID: 10465006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitomycin C analogues with a substituted hydrazine at position 7. Synthesis, spectral properties, and biological activity.
    Sawhney KN; Kohn H
    J Med Chem; 1989 Jan; 32(1):248-52. PubMed ID: 2909738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel bioreductive mitosene and mitosane analogues of mitomycin C.
    Verboom W; Reinhoudt DN; Lammerink BH; Orlemans EO; van Veggel FC; Lelieveld P
    Anticancer Drug Des; 1987 Dec; 2(3):271-7. PubMed ID: 3130071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.